Crs Bayu Ppt

Embed Size (px)

Citation preview

  • 8/18/2019 Crs Bayu Ppt

    1/28

    CASE REPORT

     TOTAL PLACENTA PREVIA

    Supervisor

    dr. Mutawakkil JP, SpO

    Prese!ted "#$

    "a#u Ewa!%%a &'('))''*''+

     

  • 8/18/2019 Crs Bayu Ppt

    2/28

    Introduction

     ANTEPARTUM HEMORRHAGE

    THE MOST COMMON IS PLACENTA PREVIA

    TYPE OF PLACENTA PREVIA• Partial placenta previa

    • Marginal placenta previa

    • Ttal placenta previa

    • L!"l#ing placenta

  • 8/18/2019 Crs Bayu Ppt

    3/28

    Patient’s Identity

      Na$e % Mr&' Y

       Age % () #

      Et*nic % S+n,ane&e

      Natinalit# % In,ne&ian

      Gra,+ate % Strata )

      Occ+patin % Teac*er  

      -ate . A,$i&&in % Oct/er )( t*0 12)3

  • 8/18/2019 Crs Bayu Ppt

    4/28

    Husband’s Identity

      Na$e % Mr&' U

       Age % (1 #

      Et*nic % S+n,ane&e

      Natinalit# % In,ne&ian

      Gra,+ate % Strata )

      Occ+patin % E$pl#e

  • 8/18/2019 Crs Bayu Ppt

    5/28

    Chief complaint

    Patient G1P)A2 c$plaint& t*at &*e get vaginal /lee,ing

  • 8/18/2019 Crs Bayu Ppt

    6/28

    Chararacteristic of this chiefcomplaint

      Since 1 *+r& /e.re t*e arrive, in

    *&pital

      Painle&& *e$rr*age

      S+,,enl# *e$rr*age

      Cntractin 456

      Fetal $ve$ent 456

  • 8/18/2019 Crs Bayu Ppt

    7/28

    History of past illness

      N *i&tr# . H#perten&in

      N *i&tr# . -ia/ete& Melit+&

       Alerg# t egg an, &ea.,

      N *i&tr# . He$atlg# -e&ea&e

      N *i&tr# . 7i,ne# -i&ea&e

      N *i&tr# . Tra+$a

      N *i&tr# . Operatin

      Fa$il# *i&tr# % ,enie,

  • 8/18/2019 Crs Bayu Ppt

    8/28

    Menstrual history

      Menarc*e % )( #

      Men&tr+al c#cle % 18 ,a#&

      La&t $en&tr+al peri, % Marc* )3t* 12)3

    Cntraceptin *i&tr# %Cntraceptive in9ectin

  • 8/18/2019 Crs Bayu Ppt

    9/28

    Gestational history

    C-ildestatio!al

    a%e &o!t-

    "irt- wei%-t &/

    a!d le!%t- &L 0ears La1or

    A%e o23-ildre!

    ears

    1

    ater$: % ((22 gr 

    L % Frget12)2 Spntane+& 3

    ( T*i&

    pregnanc#

  • 8/18/2019 Crs Bayu Ppt

    10/28

    Physical examination

    general cn,itin % $,eratel# ill

    Level . cnci+&ne&& % c$p& $enti&

    Vital &ign&

    /l, prea&&+re % )22;03C

    ?,# !eig*t % 33 @g

    ?,# *eig*t %)32 c$

    ?MI % 11 @g;$(

  • 8/18/2019 Crs Bayu Ppt

    11/28

    General examination

      E#e& % ane$ic cn9+ngtiva ";" icteric &clera ";"

      M+t* % !et $+c&al $+c+&

      T*ra=

    *eart % *eart &+n,& I an, II0 $+r$+r "0 gallp "

    l+ng % ve&ic+lar /reat* &+n,& 5;50 r*nci ";"0 !*eeing ";"

     

       A/,$en

    In&pectin % Cnve=

     A+&@+ltatin % nr$al range

    Palpatin % ten,erne&& 4"60 -e.ence M+&c+lar 4"6

    Perc+&&in % Dull  4560 &*i.ting ,+llne&& ";"

      E=tre$itie& % E,e$a ";"0 CRT B 1 &ecn,

  • 8/18/2019 Crs Bayu Ppt

    12/28

    Obstetric examination

      In&pectin% cnve=0 &triae gravi,ar+$ 456

      Palpatin Lepl, I % TFU 1>c$0 /reec*

    Lepl, II % .etal /ac@ i& at t*e rig*t &i,e an, .etal

    e=tre$ita& i& at t*e le.t &i,e

    Lepl, III % .etal *ea,

     

    Hi& % 456   A+&@+ltatin % .etal *eart )(8=;$enit0 reg+ler 

  • 8/18/2019 Crs Bayu Ppt

    13/28

    Laboratorium ndings

      *e$atlg#H/ % 80) g;,L

    Le+@c#te % D822 ;L

    He$atcrit % 1 Eritrc#te % (01 9+ta; L

    Eritrc#te in,e= MCV % .L

    MCH % 13 pg

    MCHC % (( g;,L

    Tr$/c#te % ()

  • 8/18/2019 Crs Bayu Ppt

    14/28

    upporting examination

      4S RES4LT &O3to1er '5t- ()'*

    Single .etal0 li.e0 *ea, pre&entatin0 gravi,

    (1"(( ge&tatin !ee@&0 placenta at

    p&terir crp+& cl&e all . OUI'

    Ttal placenta previa

  • 8/18/2019 Crs Bayu Ppt

    15/28

    !I"G#OI  G1P)A2 gravi,a (1"(( ge&ta&inal !it*

    pla&enta previa ,an ane$ia0 &ingletn

    .etal0 li.e0 *ea, per&entatin'

  • 8/18/2019 Crs Bayu Ppt

    16/28

    Management andtherapy   Attac* in.+&in0 cat*eter0 r+tine /l, la/

    te&t&0 prvi,e ) PRC  NST

      Ni.e,ipine ( = 12$g

      E=pectative care

  • 8/18/2019 Crs Bayu Ppt

    17/28

    $ollo% &p'

    st

     da# 2ollow up $ o3t '6

    t-

     ()'* (

    !d

     da# 2ollow up$ o3t '7

    t-

     ()'* 6

    rd

     da# 2ollow up $ o3t '*

    t-

     ()'*

    S% !a& < $nt*& pregnant0 vaginal /lee,ingO%7U% l@& ill /eing A!arene&&% c$p&$enti&T- )12;820 N 88=0 12= R0 S (8032CIn&pectin% /+lge0 &triae gravi,ar+$ 456palpatinLepl, I% TFU 1>c$0 palpa/le &.t part& an,

    le&& r+n,Lepl, II% Palpa/le *ar, part rig*t &i,elengt*!i&eLepl, III% Palpa/le *ar, part&0 r+n, an,/+nc#I$pre&&in% t*e lcatin . t*e *ea,0 /ac@rig*tHi& 456 A+&c+ltatin% ?A )(8= ; $in0 reg+lar e=a$inatin in&pe@+l

     Are nt ,nee=a$inatin In Are nt ,neE=a$inatin . H/% D'< g ; ,l A% G1P)A2 gravi,a (2"() !ee@& !it* PPTan, ane$ia% La/ I an, II0 NST0 Ni.e,ipine0 Ra!ate@&pe@tati. 

    S% $+le& an, e=it vaginal/lee,ing &lig*tl#O%7U% $il, pain A!arene&&% c$p&$enti&

    T- )22;2C- )2= ; $in+te0 *i& 456 A% G1P)A2 gravi,a (2"()!ee@& !it* PPT an, ane$ia% .+rt*er interventin0 /&-A0 ni.e,ipine (=10 /&

    general cn,itin0 vital &ign&0/e,re&t0 , v+lva *igine

    S% $+le& rarel#O%7U% G, A!arene&&% c$p&$enti&T- ))2;02C-A% )1= ; $in

     A% G1P)A2 gravi,a (2"()!ee@& !it* PPT an,ane$ia

    P% F+rt*er interventin

  • 8/18/2019 Crs Bayu Ppt

    18/28

    $ollo% &p cont'7

    t-

     da# 2ollow up $ o3t '+

    t-

     ()'* *

    t-

     da# 2ollow up$ o3t '5

    t-

     ()'* +

    t-

     da# 2ollow up $ o3t '8

    t-

     ()'*

    S% $+le& 456 O% 7U% G, A!arene&&% c$p&$enti& T- )22;=0 1= R0S (>2C a/,$en% TFU% 1> c$ FHR% )>= ; $in ?lee,ing 1 +n,e,erpa, A% G1P)A2 gravi,a (2"()

    $ngg+ !it* PPT an,ane$ia % .+rt*er interventin0nipe,ipine (=)

    O/&ervatin& in V7S% /lee,ingI a$ g, A!arene&&% c$p&$enti&T- ))2;2CHi& 4"6 TFU% 1>c$-A% )1 = ; $inLa/% H/ 8')0 le+ D8220()

  • 8/18/2019 Crs Bayu Ppt

    19/28

    $ollo% &p cont'5

    t-

     da# 2ollow up $ o3t '9

    t-

     ()'* 8

    t-

     da# 2ollow up$ o3t ()

    t-

     ()'* 9

    t-

     da# 2ollow up $ o3t ('

    st

     ()'*

    S% patient &a# nc$plaint&O%7U% g, A!arene&&% c$p&$enti&T- ))2;2CHi& 4"6-A% )1 = ; $in A% G1P)A2 (1"(( !ee@&gravi,a !it* placenta

    previa ttali& pr SC% .+rt*er interventin0cr&&$atc* 4560 ?l,PRC0 S*ave 456SC 12 Oct 12)3 at )2

    S% /lee,ing0 n ,iine&&0 n$+le&0 .etal $ve$ent& 4560le+@rea 4"60 ?A7 ; ?A? &$t*l#0n .ever0 g, appetite0 pain 4"6O%7U% g,

     A!arene&&% c$p&$enti&T- ))2;

  • 8/18/2019 Crs Bayu Ppt

    20/28

    $ollo% &p cont'')

    t-

     da# 2ollow up $ o3t ((

    !d

     ()'* ''

    t-

     da# 2ollow up$ o3t (6

    rd

     ()'*

    S% ten,erne&&0 ten,erne&&O% 7U% $,erate painCn&ci+&ne&&% CMT- ))2;

  • 8/18/2019 Crs Bayu Ppt

    21/28

    Case analysis

    )' H! i& t*e ,iagn&i& . t*i& patientJ

    1' H! i& t*e $anage$ent . t*i& patientJ

    (' :*at are t*e c$plicatin& t*at can cc+r t*i&

    patientJ

  • 8/18/2019 Crs Bayu Ppt

    22/28

    Case analysis

    )' -iagn&ing placenta previaT-eor# Case

    A!a!esis$/lee,ing

    !it*+t painOcc+rre, a.ter t*e Mnt* <?lee,ing i& repeate, an, increa&ingl#$an#Fre&* re, /l,T*e l!e&t part . t*e c*il, i& nt a/le t

    apprac* t*e inlet A/nr$alitie& la#+tHi&tr# c+rettage r cae&arean &ectin

    A!a!esis $?lee,ing .r$ t*e /irt* canal

    ?lee,ing cc+rre, 1 *+r& SMR&'Patient& &ai, t*at n! &*e !a& < $nt*&pregnant'?lee,ing cc+r& &+,,enl# an, $an#0&+c* a& .re&* /l,'Patient& al& .eel *eart/+rn ari&ing .r$ 1

    *+r& SMR&'Fetal $ve$ent i& &till perceive,

  • 8/18/2019 Crs Bayu Ppt

    23/28

    T-eor# Case

    P-#si3al e:ai!atio! $Uterine ten,erne&&0 a/,$inal ten&inan, n ten,erne&&palpa/le cntractin

    T*e l!e&t part . t*e c*il, & *ig* t*at itcan nt pa&& t*e l!e&t part . t*e pelvi&

    Spe3ulu e:ai!atio!$Vi&i/le /l, c$ing +t . t*e &e@&tern+$

    Va%i!al e:ai!atio!$Frni&e& e=a$inatin can al& /e ,ne%Palpa/le &.t c+&*in /et!een +r .inger&an, *ea, t *ea, pre&entatin

    P-#si3al e:ai!atio!$S.t +ter+&0 &t$ac* ,e& nt .eel tig*t0an, n pain

    i!spekulo Are nt ,nee:ai!atio! 2or!i3es

     Are nt ,ne

  • 8/18/2019 Crs Bayu Ppt

    24/28

    T-eor# Case

    "ia!ual e:ai!atio!Onl# per.r$e, in t*e perating r$rea,# .r &+rger# i$$e,iatel#':ill /e per.r$e, nl# !*en active

    t*erap#

    Supporti!% i!vesti%atio! $Ultra&ngrap*# 4USG6'tran&a/,$inal +ltra&+n,tran&vaginal +ltra&+n,

    MRI

    "ia!ual e:ai!atio! Are nt ,ne

    Supporti!% i!vesti%atio!$USGLive &ingle .et+& lie& t*e *ea,0 ge&tatinalage (1"(( !ee@&0 t*e placenta cver& t*e

    entire p&terir crp+& OUI' T?A% )8>gr I$pre&&in placenta previa ttali&

  • 8/18/2019 Crs Bayu Ppt

    25/28

    (' Management

    T-eor# Case 

     Active t*erap#0 Se@&i Cae&area - ter$inatin /# cae&arean &ectin

  • 8/18/2019 Crs Bayu Ppt

    26/28

    )' Complication

       Ane$ia an, &*c@

      Placenta accreta0 increta0 per@reta

       A/erratin c*il,ren

      Pre$at+re /irt* an, .etal ,i&tre&&

  • 8/18/2019 Crs Bayu Ppt

    27/28

    Conclusion

    )' T*e ,iagn&i& can $a,e /# t*e *i&tr#0

    p*#&ical e=a$ an, a,,itinal e=a$

    1' C"&ectin !a& c*&en ,+e t ttall#

    placenta previa

    (' C$plicatin n t*i& patient i& ane$ia

  • 8/18/2019 Crs Bayu Ppt

    28/28

    T;AN< 0O4